This week, we explore how molecular glues have revolutionized how we treat previously 'undruggable' cancers and explore how modern scientific techniques are teasing apart the mysteries of one of the most iconic historical artefacts with Phillip Broadwith and Neil Withers.

A ground-breaking new drug has become the first of its kind to win FDA approval for metastatic pancreatic cancer. Could it mark the beginning of a new era for cancers that have long been considered impossible to target?

We'll also uncover the chemistry behind the investigation and conservation of the Bayeux Tapestry. What secrets have scientists already revealed, and what questions about this iconic artefact remain unanswered?

Main stories:

https://www.chemistryworld.com/news/us-approves-pancreatic-cancer-treatment-that-targets-undruggable-proteins/4024110.article

https://www.chemistryworld.com/features/the-chemistry-helping-to-unravel-the-bayeux-tapestrys-secrets/4024093.article

Headlines:

https://www.chemistryworld.com/news/does-the-discovery-of-a-new-coronavirus-upend-the-covid-19-lab-leak-hypothesis/4024170.article

https://www.chemistryworld.com/news/uk-funding-agency-to-spend-66-million-on-new-methods-for-engineering-the-mitochondrial-genome/4024165.article

https://www.chemistryworld.com/news/chinas-scientific-rise-is-being-driven-by-returning-expertise-especially-chemists/4024149.article

https://www.chemistryworld.com/news/growing-confidence-of-africas-chemical-societies-brings-chemistrys-benefits-to-continent/4024137.article